SlideShare a Scribd company logo
By:-
G. TARUN
KUMAR REDDY B.pharm.,
INTRODUCTION:-
 The drug delivery systems are those which control the rate of drug
delivery, sustaining the duration of therapeutic activity and targeting the drug to
the diseased tissue.
Thereby leading the better therapeutic effect with minimum side
effects. The different types of drug delivery systems are as follows:-
EXTENDED RELEASE TABLETS
The medical advances have been made in the area of drug
delivery with the development of novel dosage forms.
The area of sustained drug delivery has granted as the most
promising type of the drug delivery system.
The sustained release or extended release drug delivery
system can be solve problems concerning the targeting of a drug to a
specific organ or tissue.
The extended release tablets will provide controlling the rate
of drug delivery.
The terms used for extended release tablets are:-
EXTENDED
RELEASE
TABLETS
DELAYED
RELEASE
TABLETS
PROLONGED
RELEASE
TABLETS
SUSTAINED
RELEASE
TABLETS
CONTROLLED
RELEASE
TABLETS
ADVANTAGES:-
1. Enhance product saftey.
2. Improved Efficacy.
3. Improved patient compliance.
4. More accurate compared to other conventional drug
delivery systems.
DISADVANTAGES:-
1. Stabilty Problems.
2. Expensive.
3. May Alter With The Food.
PHYSICOCHEMICAL PROPERTIES:
IUPAC Name : N,N-Dimethyl imidodicarbonimidic diamide
DRUG PROFILE
Appearance White or almost white crystalline Powder
Solubility Soluble in water Freely soluble as HCl salt
Molecular formula C4H11N5
Molar mass 129.16 g mol−1
log P 1.254
State Solid
Melting point 223-226 oC
pKa 12.4
BCS CLASSIFICATION Class-III
LITERATURE REVIEW
• David P Figgitt et al., The purpose of this research was to formulate
and characterize solid dispersion (SD) of metformin hydrochloride using
methocel K100M as the carrier by the solvent evaporation and cog-
rinding method.
Characterization was performed by Fourier transform spectroscopy
(FTIR), ultraviolet,
The optimized formulation was subjected to accelerated stability
testing as per ICH guidelines.
• Basavaraj.k Nanjwade et al., To develop and characterize an oral
Prolonged-release matrix tablet of metformin hydrochloride using a
combination of a hydrophobic carrier and hydrophilic polymer and two
types of formulation techniques.
P. K. Bhoyar et al ., An attempt was made to sustain the release of
metformin HCl as well as to mask the bitter taste by complexation
technique using strong cation-exchange resins.
The drug loading into ion-exchange resin was optimized for mixing
time, activation, effect of pH, mode of mixing, ratio of drug:resin
and temperature.
The resinate was evaluated for micromeritic properties, taste
masking and characterized using IR. Using resinate sustained
release tablets were.
AIM
 Formulation and evaluation of prolonged release of Metformin
Hydrochloride Tablets.
OBJECTIVE
Under these considerations, objective of the work is
 To design the formula for Metformin Hcl ER tablets.
 To incorporate selected model drug candidates in the same formula and
prepare tablets.
 To evaluate the prepared tablets of Metformin hydrochloride.
 To study the in-vitro dissolution profile of prepared tablets.
 Stability evaluation studies were carried out.
PLAN OF WORK
Preformulation studies :-
*API characterization
*Organoleptic evaluation
*Solubility
*Analytical evaluation
*Bulk density
*Tapped density
*Angle of repose
*Compressibility index
Evaluation Of Tablets
Post Formulation Studies:-
Hardness
Uniformity of thickness
Friability
Weight variation
Content uniformity
In vitro dissolution Stability studies.
Extented release tablets containing 500 mg of model drug
were prepared with a total tablet weight of 750mg.
Considering the pre-formulation studies and the literature
survey conducted the excipients were selected and an
attempt to produce prolonged released tablets.
Add the lubricant (magnesium stearate)
COMPRESSS the blend for tablet formation
PASS THROUGH SIEVE (No:-40)
DIRECT COMPRESSION METHOD
METFORMIN BINDER(POVIDONE)+
ADD DILUENT
METHOD:
1. The powder blend is subjected to drying and was
compressed by direct compression method by using
Standard concave punches in 8 Station Kambet KMPC8
tablet punching machine
2. Punches of 17.5mm and 7mm diameter were used for
compression.
3. Tablet of 748mg and 753mg was prepared in different
trials by adjusting hardness and volume screw of
compression machine properly.
WET GRANULATION METHOD
Drug + polymer
Pass through sieve
No:- 40
Add Diluent , half part of binder Then Pass
through sieve(sieve No.40)
DM water
Prepare granules and lubricated it
with Magnesium sterate (pre-sifted
through sieve No. 60) mix 5 minutes
Subject the blend for
tablet formulation
(compression)
• METHOD:-
Compress with punches in 8 Station Kambet
KMPC8 tablet punching machine.
Standard concave punches of 17.5mm, with
breakline punches measuring the Tablet of
750mg,770mg,740mg and 760mg was prepared in
different trials by adjusting hardness and volume
screw of compression machine properly.
DEVELOPMENT OF METFORMIN OF PROLONGED
RELEASE TABLETS
Formula
INGREDIENTS Mg/Tab(T1)
API 500
Polyox-303 50
Lactose monohydrate 190
Mg Stearate 10
Total Weight 750
PRE-FORMULATION OF API
I. Pre Compression Parameters
1.Angle of Repose
The angle of repose has been used to characterize the flow
properties of solids.
This is the maximum angle possible between surface of pile of
powder or granules and the horizontal plane.
It was calculated using the following equation:-
Tanθ = h / r
θ = tan –1 h / r
Where, h = height of the powder heap
r = radius of the powder heap
θ= angle of repose
2.Bulk density:
Bulk density defined as the mass of many particles of the material
divided by the total volume they occupy.
The total volume includes particle volume, inter-particle void
volume, and internal pore volume.
Bulk density is not an intrinsic property of a material.
Bulk density = Weight of powder(g) / Bulk volume(ml)
3.Tapped density:-
Tapped densitiy of the drug was determined by pouring 25 gm
through a glass funnel into a 100 ml cylinder.
The cylinder was tapped from height of 2 inches until a constant
volume was obtained.
The volume occupied by the sample after tappings were recorded
and the tapped density was calculated by the formula below
Tapped density = Weight of powder(g) / Tapped volume(ml)
4.Carr’s compressibility index:-
Compressibility is the ability of powder to decrease in volume
under pressure.
It is one of the method to determine the flow properties by
comparing the bulk and tapped densities.
% Compressibility Flow description
<10 Excellent
11-15 Good
16-20 Fair
21-25 Passable
26-31 Poor
32-37 Very poor
>38 Extremely poor
Carr’s index of each formulation was calculated according to
equation given below:-
Tapped density – Bulk density
Tapped density
X 100Carr’s index =
II. Post- compression parameters:
The quantitative evaluation of a tablet’s chemical, physical and
bioavailability properties are important in the design of tablets and to
monitor product quality.
• General appearance:-
The general appearance of tablets, its visual identity is essential
for consumer acceptance, control of lot-to-lot uniformity and general
tablet-to-tablet uniformity.
The control of general appearance involves measurement
attributes such as
Tablet’s size
Shape
Color
Presence or absence of odour
Taste
Surface textures & etc.
• Hardness or crushing strength:-
The resistance of tablets to capping, abrasion or
breakage under conditions of storage, transportation and
handling before usage depends on its hardness.
It is measured either by Monsanto or Stokes hardness
tester, by applying pressure diametrally to the tablet.
Monsanto Hardness Tester
RESULT
IDENTIFICATION OF DRUG:
By UV Spectroscopy:
Determination of max of Anti hyperglycemic agent:
On the basis of preliminary identification test the drug scanned
and it was concluded that the drug had max of 232 nm
which was equal to max 232nm as reported (std.).
SPECTRUM POINT PICK METHOD
STABILITY STUDIES
 The stability studies were carried out by storing in HDPE containers under the
Accelerated stability conditions of 40ºC /70% RH for a period of 1 month.
 The tablets were evaluated for the parameters like weight variation, hardness,
friability, thickness, and percentage of drug content were evaluated for initial, 1st, 2nd,
3rd and 1month.
 The tablets displayed all parameters of optimized formulation F10 within specified
limits indicating the stability of the formulation.
Parameters 1st week 2nd week 3rd week 4th week
Weight variation (mg) 750±5 750±4 750±4 750±4
Thickness (mm) 5.75±0.6 5.75±0.7 5.75±0.7 5.74±0.6
Hardness (N) 180 ± 10 190 ± 10 185±10 180 ± 20
Friability (%) 0.045 0.15 0.15 0.015
Drug Content (%) 97 96 95 94
Stability Studies Of Metformin Prolonged Release Tablets
Stability Effect On In-Vitro Dissolution Of Optimized Formulation (F10) at 1,2,3&4 week.
Time (Hours)
% Drug Release
1st week 2nd week 3rd week 4th week
0 0 0 0 0
1 30 25 28 27
2 42 40 39 44
3 54 54 52 53
6 76 773 74 74
10 98 96 96 95
Stability Effect On In Vitro Drug release profile of Trial-10
BIBLIOGRAPHY
•United States pharmacopoeia (2008) Bulk density and tapped density,
Carr’s index and Hausner’s ratio, USPNF 2008, vol-1, page no: 231-
232.
•Indian Pharmacopoeia (2012) Uniformity of weight of single dose
preparations, Friability, 2010, vol-1, page no: 140, 192-193.
•Lachman L. and Lieberman H.A., Pharmaceutical Dosage Forms, In;
Tablets, Vol. 2, Marcel Dekker, Inc., New York ,1989 pp.367-414
•Martin,A.; Physical pharmacy; Fourth edition ; PP 444-445.
•www.wikipedia.org/wiki/tablets
•www.pharmainfo.net/tablets/types-tablets
Remington The Science and Practice of Pharmacy, 21st edition Vol.-1,
Page No.1178-1198
•www.Drugbank.com
•Brahmankar D.M., Jaiswal S.B., “Biopharmaceutics &
Pharmacokinetics”; First Edition; p-335 (1995).
•Tripathi KD, Essential of medical pharmacology, 5th ed.New Delhi:
Jaypeebrothepublishing house;2003, 254-275.
•United States pharmacopoeia (2012) Bulk density and tapped
density, Carr’s index and Hausner’s ratio, USPNF 2008, vol-1, page
no: 231-232.
•Indian Pharmacopoeia (2012) Uniformity of weight of single dose
preparations, Friability, 2010, vol-1, page no: 140, 192-193.
•British Pharmacopoeia (2012) Angle of repose, vol-5, Appendix-
A465.
•http://www.researchwikis.com/Generics_Market_Analysis_Marketin
g_ Research.
•United States pharmacopoeia (2012) Bulk density and tapped density,
Carr’s index and Hausner’s ratio, USPNF 2008, vol-1, page no: 231-
232.
Metformin hydrochloride

More Related Content

What's hot

evaluation of gastro retentive drug delivery system (GRDDS)
evaluation of gastro retentive drug delivery system (GRDDS)evaluation of gastro retentive drug delivery system (GRDDS)
evaluation of gastro retentive drug delivery system (GRDDS)
Imran Pasha
 
MODIFIED RELEASE DRUG DELIVERY SYSTEM
MODIFIED RELEASE DRUG DELIVERY SYSTEMMODIFIED RELEASE DRUG DELIVERY SYSTEM
MODIFIED RELEASE DRUG DELIVERY SYSTEM
Shiv kumar
 
Biowaiver
BiowaiverBiowaiver
quality control test for soft gelatin capsule and minim per gram factor
quality control test for soft gelatin capsule and minim per gram factorquality control test for soft gelatin capsule and minim per gram factor
quality control test for soft gelatin capsule and minim per gram factor
SUJIT DAS
 
Four Levels of In-Vitro-In-Vivo Correlation
Four Levels of In-Vitro-In-Vivo CorrelationFour Levels of In-Vitro-In-Vivo Correlation
Four Levels of In-Vitro-In-Vivo Correlation
Bhaswat Chakraborty
 
Physicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of DrugsPhysicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of Drugs
Suraj Choudhary
 
TESTS ON FORMULATIONS: Content Uniformity, Hardness, Dissolution.
TESTS ON FORMULATIONS: Content Uniformity, Hardness, Dissolution.TESTS ON FORMULATIONS: Content Uniformity, Hardness, Dissolution.
TESTS ON FORMULATIONS: Content Uniformity, Hardness, Dissolution.Amruta Sonawane
 
Sustained release dosage form
Sustained release dosage formSustained release dosage form
Sustained release dosage form
Sujit Patel
 
Theories of Dissolution
Theories of DissolutionTheories of Dissolution
Theories of Dissolution
PRASHANT DEORE
 
IN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATIONIN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATION
N Anusha
 
Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]
Sagar Savale
 
Parenteral Products
Parenteral ProductsParenteral Products
Parenteral Products
Rishi Ram Parajuli
 
FORMULATION TECHNOLOGY PRACTICAL MANUAL
FORMULATION TECHNOLOGY PRACTICAL MANUALFORMULATION TECHNOLOGY PRACTICAL MANUAL
FORMULATION TECHNOLOGY PRACTICAL MANUAL
Reshma Fathima .K
 
Quality control tests of tablet
Quality control tests of tabletQuality control tests of tablet
Quality control tests of tablet
SarangDalvi
 
IVIVC
IVIVCIVIVC
Parenteral formulations
Parenteral formulationsParenteral formulations
Parenteral formulations
Sayeda Salma S.A.
 
QUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULESQUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULES
Ramya priya
 
TABLET COMPRESSION
TABLET COMPRESSIONTABLET COMPRESSION
TABLET COMPRESSION
SAJJAD AHMAD
 
Dry granulation
Dry granulationDry granulation
Dry granulation
Geraldo Garcia
 

What's hot (20)

evaluation of gastro retentive drug delivery system (GRDDS)
evaluation of gastro retentive drug delivery system (GRDDS)evaluation of gastro retentive drug delivery system (GRDDS)
evaluation of gastro retentive drug delivery system (GRDDS)
 
MODIFIED RELEASE DRUG DELIVERY SYSTEM
MODIFIED RELEASE DRUG DELIVERY SYSTEMMODIFIED RELEASE DRUG DELIVERY SYSTEM
MODIFIED RELEASE DRUG DELIVERY SYSTEM
 
Biowaiver
BiowaiverBiowaiver
Biowaiver
 
quality control test for soft gelatin capsule and minim per gram factor
quality control test for soft gelatin capsule and minim per gram factorquality control test for soft gelatin capsule and minim per gram factor
quality control test for soft gelatin capsule and minim per gram factor
 
Four Levels of In-Vitro-In-Vivo Correlation
Four Levels of In-Vitro-In-Vivo CorrelationFour Levels of In-Vitro-In-Vivo Correlation
Four Levels of In-Vitro-In-Vivo Correlation
 
Physicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of DrugsPhysicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of Drugs
 
TESTS ON FORMULATIONS: Content Uniformity, Hardness, Dissolution.
TESTS ON FORMULATIONS: Content Uniformity, Hardness, Dissolution.TESTS ON FORMULATIONS: Content Uniformity, Hardness, Dissolution.
TESTS ON FORMULATIONS: Content Uniformity, Hardness, Dissolution.
 
Sustained release dosage form
Sustained release dosage formSustained release dosage form
Sustained release dosage form
 
Theories of Dissolution
Theories of DissolutionTheories of Dissolution
Theories of Dissolution
 
IN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATIONIN VITRO - IN VIVO CORRELATION
IN VITRO - IN VIVO CORRELATION
 
Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]
 
Parenteral Products
Parenteral ProductsParenteral Products
Parenteral Products
 
Pilot plant tablets
Pilot  plant tabletsPilot  plant tablets
Pilot plant tablets
 
FORMULATION TECHNOLOGY PRACTICAL MANUAL
FORMULATION TECHNOLOGY PRACTICAL MANUALFORMULATION TECHNOLOGY PRACTICAL MANUAL
FORMULATION TECHNOLOGY PRACTICAL MANUAL
 
Quality control tests of tablet
Quality control tests of tabletQuality control tests of tablet
Quality control tests of tablet
 
IVIVC
IVIVCIVIVC
IVIVC
 
Parenteral formulations
Parenteral formulationsParenteral formulations
Parenteral formulations
 
QUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULESQUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULES
 
TABLET COMPRESSION
TABLET COMPRESSIONTABLET COMPRESSION
TABLET COMPRESSION
 
Dry granulation
Dry granulationDry granulation
Dry granulation
 

Viewers also liked

Metformin A Pharmacological Preespective
Metformin A Pharmacological PreespectiveMetformin A Pharmacological Preespective
Metformin A Pharmacological Preespective
Dr. AsadUllah
 
Effect of ethanolic extract of piper cubeba linn fruits on activity of piogli...
Effect of ethanolic extract of piper cubeba linn fruits on activity of piogli...Effect of ethanolic extract of piper cubeba linn fruits on activity of piogli...
Effect of ethanolic extract of piper cubeba linn fruits on activity of piogli...
srirampharma
 
Metformin is a revolutionary anti diabetic drug
Metformin is a revolutionary anti diabetic drugMetformin is a revolutionary anti diabetic drug
Metformin is a revolutionary anti diabetic drug
purebusiness
 
Med Basics: Metformin
Med Basics: MetforminMed Basics: Metformin
Med Basics: Metformin
MedSimple
 
Metformin PowerPoint
Metformin PowerPointMetformin PowerPoint
Metformin PowerPoint
mashley3
 
Metformin
MetforminMetformin
Metformin
drtvnrao
 
Metformin
MetforminMetformin
Metformin
gowri shanker
 
Metformin presentation sigma xi
Metformin presentation sigma xiMetformin presentation sigma xi
Metformin presentation sigma xi
Laceyg92
 
Monitoring the effectiveness of risk minimisation in patients treated with pi...
Monitoring the effectiveness of risk minimisation in patients treated with pi...Monitoring the effectiveness of risk minimisation in patients treated with pi...
Monitoring the effectiveness of risk minimisation in patients treated with pi...
Valeria Antonella Aguirre
 
26.09 metformain as a antiaterosceoti
26.09 metformain as a antiaterosceoti26.09 metformain as a antiaterosceoti
26.09 metformain as a antiaterosceotiRajeev Agarwala
 
Деятельность и направление Смарт Секьюрити
Деятельность и направление Смарт СекьюритиДеятельность и направление Смарт Секьюрити
Деятельность и направление Смарт Секьюрити
volovetskamaria
 
Электронные сирены и аксессуары
Электронные сирены и аксессуарыЭлектронные сирены и аксессуары
Электронные сирены и аксессуары
volovetskamaria
 
Server oko
Server okoServer oko
Server oko
volovetskamaria
 
Franchise x escape com
Franchise x escape comFranchise x escape com
Franchise x escape com
volovetskamaria
 
Презентация дигидрол
Презентация дигидролПрезентация дигидрол
Презентация дигидрол
volovetskamaria
 
каталоог светофоры 01 11_15
каталоог светофоры 01 11_15каталоог светофоры 01 11_15
каталоог светофоры 01 11_15
volovetskamaria
 
White paper
White paperWhite paper
White paper
volovetskamaria
 
Camomilla italia catalogue spring 2015
Camomilla italia catalogue spring 2015Camomilla italia catalogue spring 2015
Camomilla italia catalogue spring 2015
volovetskamaria
 

Viewers also liked (20)

Metformin A Pharmacological Preespective
Metformin A Pharmacological PreespectiveMetformin A Pharmacological Preespective
Metformin A Pharmacological Preespective
 
Effect of ethanolic extract of piper cubeba linn fruits on activity of piogli...
Effect of ethanolic extract of piper cubeba linn fruits on activity of piogli...Effect of ethanolic extract of piper cubeba linn fruits on activity of piogli...
Effect of ethanolic extract of piper cubeba linn fruits on activity of piogli...
 
Metformin is a revolutionary anti diabetic drug
Metformin is a revolutionary anti diabetic drugMetformin is a revolutionary anti diabetic drug
Metformin is a revolutionary anti diabetic drug
 
Diabetic Presentation Corrected
Diabetic Presentation CorrectedDiabetic Presentation Corrected
Diabetic Presentation Corrected
 
Med Basics: Metformin
Med Basics: MetforminMed Basics: Metformin
Med Basics: Metformin
 
Metformin PowerPoint
Metformin PowerPointMetformin PowerPoint
Metformin PowerPoint
 
Metformin
MetforminMetformin
Metformin
 
Metformin
MetforminMetformin
Metformin
 
Metformin presentation sigma xi
Metformin presentation sigma xiMetformin presentation sigma xi
Metformin presentation sigma xi
 
Monitoring the effectiveness of risk minimisation in patients treated with pi...
Monitoring the effectiveness of risk minimisation in patients treated with pi...Monitoring the effectiveness of risk minimisation in patients treated with pi...
Monitoring the effectiveness of risk minimisation in patients treated with pi...
 
26.09 metformain as a antiaterosceoti
26.09 metformain as a antiaterosceoti26.09 metformain as a antiaterosceoti
26.09 metformain as a antiaterosceoti
 
Деятельность и направление Смарт Секьюрити
Деятельность и направление Смарт СекьюритиДеятельность и направление Смарт Секьюрити
Деятельность и направление Смарт Секьюрити
 
Электронные сирены и аксессуары
Электронные сирены и аксессуарыЭлектронные сирены и аксессуары
Электронные сирены и аксессуары
 
Server oko
Server okoServer oko
Server oko
 
Franchise x escape com
Franchise x escape comFranchise x escape com
Franchise x escape com
 
Презентация дигидрол
Презентация дигидролПрезентация дигидрол
Презентация дигидрол
 
каталоог светофоры 01 11_15
каталоог светофоры 01 11_15каталоог светофоры 01 11_15
каталоог светофоры 01 11_15
 
White paper
White paperWhite paper
White paper
 
Ba lô dây rút
Ba lô dây rútBa lô dây rút
Ba lô dây rút
 
Camomilla italia catalogue spring 2015
Camomilla italia catalogue spring 2015Camomilla italia catalogue spring 2015
Camomilla italia catalogue spring 2015
 

Similar to Metformin hydrochloride

Formulation and evaluation of bi-layered floating tablets of metformin and te...
Formulation and evaluation of bi-layered floating tablets of metformin and te...Formulation and evaluation of bi-layered floating tablets of metformin and te...
Formulation and evaluation of bi-layered floating tablets of metformin and te...
SriramNagarajan17
 
Sustained release drug deliveru system
Sustained release drug deliveru systemSustained release drug deliveru system
Sustained release drug deliveru system
Pooja Sadgir
 
Formulation and Evaluation of Floating Tablets using Nimesulide as a Model Drug
Formulation and Evaluation of Floating Tablets using Nimesulide as a Model DrugFormulation and Evaluation of Floating Tablets using Nimesulide as a Model Drug
Formulation and Evaluation of Floating Tablets using Nimesulide as a Model Drug
IRJET Journal
 
Preformulation/pharmaceutical preformulation
Preformulation/pharmaceutical preformulationPreformulation/pharmaceutical preformulation
Preformulation/pharmaceutical preformulation
M R S
 
Formulation and invitro evaluation of gastro retentive floating mini tablets ...
Formulation and invitro evaluation of gastro retentive floating mini tablets ...Formulation and invitro evaluation of gastro retentive floating mini tablets ...
Formulation and invitro evaluation of gastro retentive floating mini tablets ...
SriramNagarajan17
 
Formulation and In vitro evaluation of Fosinopril fast dissolving tablets
Formulation and In vitro evaluation of Fosinopril fast dissolving tabletsFormulation and In vitro evaluation of Fosinopril fast dissolving tablets
Formulation and In vitro evaluation of Fosinopril fast dissolving tablets
SriramNagarajan18
 
Pavan.s
Pavan.sPavan.s
Pavan.s
Stalin243932
 
My final year presentation
My final year presentationMy final year presentation
My final year presentation
Pramod Bhosale
 
Formulation and evaluation of Furosemide oral dispersible tablets
Formulation and evaluation of Furosemide oral dispersible tabletsFormulation and evaluation of Furosemide oral dispersible tablets
Formulation and evaluation of Furosemide oral dispersible tablets
SriramNagarajan18
 
Ijpar 14 619 sreekanth goudDesign and evaluation of Bilayered tablets of Simv...
Ijpar 14 619 sreekanth goudDesign and evaluation of Bilayered tablets of Simv...Ijpar 14 619 sreekanth goudDesign and evaluation of Bilayered tablets of Simv...
Ijpar 14 619 sreekanth goudDesign and evaluation of Bilayered tablets of Simv...
pharmaindexing
 
Stability study slideshare
Stability study slideshareStability study slideshare
Stability study slideshare
AsgharullahKhan
 
QC & QA IPQC & FPQC
QC & QA  IPQC & FPQCQC & QA  IPQC & FPQC
QC & QA IPQC & FPQC
Venkatesan R - 6369851191
 
Formulation development of pharmaceutical drug
Formulation development of pharmaceutical drugFormulation development of pharmaceutical drug
Formulation development of pharmaceutical drug
SriramPraveen5
 
Floating tablet
Floating tabletFloating tablet
Floating tablet
Sagar Savale
 
IPQC and FPQC for tablets
IPQC and FPQC for tabletsIPQC and FPQC for tablets
IPQC and FPQC for tablets
Mukesh Patil
 
FORMULATION DEVELOPMENT OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE BILAYERED...
FORMULATION DEVELOPMENT OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE BILAYERED...FORMULATION DEVELOPMENT OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE BILAYERED...
FORMULATION DEVELOPMENT OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE BILAYERED...
ANURAG GROUP OF INSTITUTIONS
 
Effervescent technique in development of floating tablets for antiviral drugs
Effervescent technique in development of floating tablets for antiviral drugsEffervescent technique in development of floating tablets for antiviral drugs
Effervescent technique in development of floating tablets for antiviral drugs
SriramNagarajan19
 
Preparation and evaluation of sustained release matrix tablets of Repaglinide...
Preparation and evaluation of sustained release matrix tablets of Repaglinide...Preparation and evaluation of sustained release matrix tablets of Repaglinide...
Preparation and evaluation of sustained release matrix tablets of Repaglinide...
SriramNagarajan18
 
Quality control complete notes
Quality control complete notesQuality control complete notes
Quality control complete notes
Ghulam Murtaza Hamad
 

Similar to Metformin hydrochloride (20)

Formulation and evaluation of bi-layered floating tablets of metformin and te...
Formulation and evaluation of bi-layered floating tablets of metformin and te...Formulation and evaluation of bi-layered floating tablets of metformin and te...
Formulation and evaluation of bi-layered floating tablets of metformin and te...
 
Sustained release drug deliveru system
Sustained release drug deliveru systemSustained release drug deliveru system
Sustained release drug deliveru system
 
Formulation and Evaluation of Floating Tablets using Nimesulide as a Model Drug
Formulation and Evaluation of Floating Tablets using Nimesulide as a Model DrugFormulation and Evaluation of Floating Tablets using Nimesulide as a Model Drug
Formulation and Evaluation of Floating Tablets using Nimesulide as a Model Drug
 
Preformulation/pharmaceutical preformulation
Preformulation/pharmaceutical preformulationPreformulation/pharmaceutical preformulation
Preformulation/pharmaceutical preformulation
 
Formulation and invitro evaluation of gastro retentive floating mini tablets ...
Formulation and invitro evaluation of gastro retentive floating mini tablets ...Formulation and invitro evaluation of gastro retentive floating mini tablets ...
Formulation and invitro evaluation of gastro retentive floating mini tablets ...
 
Formulation and In vitro evaluation of Fosinopril fast dissolving tablets
Formulation and In vitro evaluation of Fosinopril fast dissolving tabletsFormulation and In vitro evaluation of Fosinopril fast dissolving tablets
Formulation and In vitro evaluation of Fosinopril fast dissolving tablets
 
Pavan.s
Pavan.sPavan.s
Pavan.s
 
My final year presentation
My final year presentationMy final year presentation
My final year presentation
 
Formulation and evaluation of Furosemide oral dispersible tablets
Formulation and evaluation of Furosemide oral dispersible tabletsFormulation and evaluation of Furosemide oral dispersible tablets
Formulation and evaluation of Furosemide oral dispersible tablets
 
@Ndd
@Ndd@Ndd
@Ndd
 
Ijpar 14 619 sreekanth goudDesign and evaluation of Bilayered tablets of Simv...
Ijpar 14 619 sreekanth goudDesign and evaluation of Bilayered tablets of Simv...Ijpar 14 619 sreekanth goudDesign and evaluation of Bilayered tablets of Simv...
Ijpar 14 619 sreekanth goudDesign and evaluation of Bilayered tablets of Simv...
 
Stability study slideshare
Stability study slideshareStability study slideshare
Stability study slideshare
 
QC & QA IPQC & FPQC
QC & QA  IPQC & FPQCQC & QA  IPQC & FPQC
QC & QA IPQC & FPQC
 
Formulation development of pharmaceutical drug
Formulation development of pharmaceutical drugFormulation development of pharmaceutical drug
Formulation development of pharmaceutical drug
 
Floating tablet
Floating tabletFloating tablet
Floating tablet
 
IPQC and FPQC for tablets
IPQC and FPQC for tabletsIPQC and FPQC for tablets
IPQC and FPQC for tablets
 
FORMULATION DEVELOPMENT OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE BILAYERED...
FORMULATION DEVELOPMENT OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE BILAYERED...FORMULATION DEVELOPMENT OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE BILAYERED...
FORMULATION DEVELOPMENT OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE BILAYERED...
 
Effervescent technique in development of floating tablets for antiviral drugs
Effervescent technique in development of floating tablets for antiviral drugsEffervescent technique in development of floating tablets for antiviral drugs
Effervescent technique in development of floating tablets for antiviral drugs
 
Preparation and evaluation of sustained release matrix tablets of Repaglinide...
Preparation and evaluation of sustained release matrix tablets of Repaglinide...Preparation and evaluation of sustained release matrix tablets of Repaglinide...
Preparation and evaluation of sustained release matrix tablets of Repaglinide...
 
Quality control complete notes
Quality control complete notesQuality control complete notes
Quality control complete notes
 

More from Tarun Kumar Reddy

Regulatory Affairs role in Pharmaceutical Industry
Regulatory Affairs role in Pharmaceutical IndustryRegulatory Affairs role in Pharmaceutical Industry
Regulatory Affairs role in Pharmaceutical Industry
Tarun Kumar Reddy
 
Formulation and evaluation of nanoparticles as a drug delivery systems
Formulation and evaluation of nanoparticles as a drug delivery systems Formulation and evaluation of nanoparticles as a drug delivery systems
Formulation and evaluation of nanoparticles as a drug delivery systems
Tarun Kumar Reddy
 
National Drug Policy
National Drug Policy National Drug Policy
National Drug Policy
Tarun Kumar Reddy
 
Prescription Drug User Fee Act
Prescription Drug User Fee ActPrescription Drug User Fee Act
Prescription Drug User Fee Act
Tarun Kumar Reddy
 
Medical devices
Medical devicesMedical devices
Medical devices
Tarun Kumar Reddy
 
Nda and Anda
Nda and AndaNda and Anda
Nda and Anda
Tarun Kumar Reddy
 
Xrd
XrdXrd
Pharmacognosy a quick review
Pharmacognosy a quick reviewPharmacognosy a quick review
Pharmacognosy a quick review
Tarun Kumar Reddy
 

More from Tarun Kumar Reddy (8)

Regulatory Affairs role in Pharmaceutical Industry
Regulatory Affairs role in Pharmaceutical IndustryRegulatory Affairs role in Pharmaceutical Industry
Regulatory Affairs role in Pharmaceutical Industry
 
Formulation and evaluation of nanoparticles as a drug delivery systems
Formulation and evaluation of nanoparticles as a drug delivery systems Formulation and evaluation of nanoparticles as a drug delivery systems
Formulation and evaluation of nanoparticles as a drug delivery systems
 
National Drug Policy
National Drug Policy National Drug Policy
National Drug Policy
 
Prescription Drug User Fee Act
Prescription Drug User Fee ActPrescription Drug User Fee Act
Prescription Drug User Fee Act
 
Medical devices
Medical devicesMedical devices
Medical devices
 
Nda and Anda
Nda and AndaNda and Anda
Nda and Anda
 
Xrd
XrdXrd
Xrd
 
Pharmacognosy a quick review
Pharmacognosy a quick reviewPharmacognosy a quick review
Pharmacognosy a quick review
 

Recently uploaded

Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 

Recently uploaded (20)

Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 

Metformin hydrochloride

  • 2. INTRODUCTION:- The drug delivery systems are those which control the rate of drug delivery, sustaining the duration of therapeutic activity and targeting the drug to the diseased tissue. Thereby leading the better therapeutic effect with minimum side effects. The different types of drug delivery systems are as follows:-
  • 3. EXTENDED RELEASE TABLETS The medical advances have been made in the area of drug delivery with the development of novel dosage forms. The area of sustained drug delivery has granted as the most promising type of the drug delivery system. The sustained release or extended release drug delivery system can be solve problems concerning the targeting of a drug to a specific organ or tissue. The extended release tablets will provide controlling the rate of drug delivery.
  • 4. The terms used for extended release tablets are:- EXTENDED RELEASE TABLETS DELAYED RELEASE TABLETS PROLONGED RELEASE TABLETS SUSTAINED RELEASE TABLETS CONTROLLED RELEASE TABLETS
  • 5. ADVANTAGES:- 1. Enhance product saftey. 2. Improved Efficacy. 3. Improved patient compliance. 4. More accurate compared to other conventional drug delivery systems. DISADVANTAGES:- 1. Stabilty Problems. 2. Expensive. 3. May Alter With The Food.
  • 6. PHYSICOCHEMICAL PROPERTIES: IUPAC Name : N,N-Dimethyl imidodicarbonimidic diamide DRUG PROFILE Appearance White or almost white crystalline Powder Solubility Soluble in water Freely soluble as HCl salt Molecular formula C4H11N5 Molar mass 129.16 g mol−1 log P 1.254 State Solid Melting point 223-226 oC pKa 12.4 BCS CLASSIFICATION Class-III
  • 7.
  • 8. LITERATURE REVIEW • David P Figgitt et al., The purpose of this research was to formulate and characterize solid dispersion (SD) of metformin hydrochloride using methocel K100M as the carrier by the solvent evaporation and cog- rinding method. Characterization was performed by Fourier transform spectroscopy (FTIR), ultraviolet, The optimized formulation was subjected to accelerated stability testing as per ICH guidelines. • Basavaraj.k Nanjwade et al., To develop and characterize an oral Prolonged-release matrix tablet of metformin hydrochloride using a combination of a hydrophobic carrier and hydrophilic polymer and two types of formulation techniques.
  • 9. P. K. Bhoyar et al ., An attempt was made to sustain the release of metformin HCl as well as to mask the bitter taste by complexation technique using strong cation-exchange resins. The drug loading into ion-exchange resin was optimized for mixing time, activation, effect of pH, mode of mixing, ratio of drug:resin and temperature. The resinate was evaluated for micromeritic properties, taste masking and characterized using IR. Using resinate sustained release tablets were.
  • 10. AIM  Formulation and evaluation of prolonged release of Metformin Hydrochloride Tablets. OBJECTIVE Under these considerations, objective of the work is  To design the formula for Metformin Hcl ER tablets.  To incorporate selected model drug candidates in the same formula and prepare tablets.  To evaluate the prepared tablets of Metformin hydrochloride.  To study the in-vitro dissolution profile of prepared tablets.  Stability evaluation studies were carried out.
  • 11. PLAN OF WORK Preformulation studies :- *API characterization *Organoleptic evaluation *Solubility *Analytical evaluation *Bulk density *Tapped density *Angle of repose *Compressibility index
  • 12. Evaluation Of Tablets Post Formulation Studies:- Hardness Uniformity of thickness Friability Weight variation Content uniformity In vitro dissolution Stability studies.
  • 13. Extented release tablets containing 500 mg of model drug were prepared with a total tablet weight of 750mg. Considering the pre-formulation studies and the literature survey conducted the excipients were selected and an attempt to produce prolonged released tablets.
  • 14. Add the lubricant (magnesium stearate) COMPRESSS the blend for tablet formation PASS THROUGH SIEVE (No:-40) DIRECT COMPRESSION METHOD METFORMIN BINDER(POVIDONE)+ ADD DILUENT
  • 15. METHOD: 1. The powder blend is subjected to drying and was compressed by direct compression method by using Standard concave punches in 8 Station Kambet KMPC8 tablet punching machine 2. Punches of 17.5mm and 7mm diameter were used for compression. 3. Tablet of 748mg and 753mg was prepared in different trials by adjusting hardness and volume screw of compression machine properly.
  • 16. WET GRANULATION METHOD Drug + polymer Pass through sieve No:- 40 Add Diluent , half part of binder Then Pass through sieve(sieve No.40) DM water Prepare granules and lubricated it with Magnesium sterate (pre-sifted through sieve No. 60) mix 5 minutes Subject the blend for tablet formulation (compression)
  • 17. • METHOD:- Compress with punches in 8 Station Kambet KMPC8 tablet punching machine. Standard concave punches of 17.5mm, with breakline punches measuring the Tablet of 750mg,770mg,740mg and 760mg was prepared in different trials by adjusting hardness and volume screw of compression machine properly.
  • 18. DEVELOPMENT OF METFORMIN OF PROLONGED RELEASE TABLETS Formula INGREDIENTS Mg/Tab(T1) API 500 Polyox-303 50 Lactose monohydrate 190 Mg Stearate 10 Total Weight 750
  • 19. PRE-FORMULATION OF API I. Pre Compression Parameters 1.Angle of Repose The angle of repose has been used to characterize the flow properties of solids. This is the maximum angle possible between surface of pile of powder or granules and the horizontal plane. It was calculated using the following equation:- Tanθ = h / r θ = tan –1 h / r Where, h = height of the powder heap r = radius of the powder heap θ= angle of repose
  • 20. 2.Bulk density: Bulk density defined as the mass of many particles of the material divided by the total volume they occupy. The total volume includes particle volume, inter-particle void volume, and internal pore volume. Bulk density is not an intrinsic property of a material. Bulk density = Weight of powder(g) / Bulk volume(ml)
  • 21. 3.Tapped density:- Tapped densitiy of the drug was determined by pouring 25 gm through a glass funnel into a 100 ml cylinder. The cylinder was tapped from height of 2 inches until a constant volume was obtained. The volume occupied by the sample after tappings were recorded and the tapped density was calculated by the formula below Tapped density = Weight of powder(g) / Tapped volume(ml)
  • 22. 4.Carr’s compressibility index:- Compressibility is the ability of powder to decrease in volume under pressure. It is one of the method to determine the flow properties by comparing the bulk and tapped densities. % Compressibility Flow description <10 Excellent 11-15 Good 16-20 Fair 21-25 Passable 26-31 Poor 32-37 Very poor >38 Extremely poor
  • 23. Carr’s index of each formulation was calculated according to equation given below:- Tapped density – Bulk density Tapped density X 100Carr’s index =
  • 24. II. Post- compression parameters: The quantitative evaluation of a tablet’s chemical, physical and bioavailability properties are important in the design of tablets and to monitor product quality. • General appearance:- The general appearance of tablets, its visual identity is essential for consumer acceptance, control of lot-to-lot uniformity and general tablet-to-tablet uniformity. The control of general appearance involves measurement attributes such as Tablet’s size Shape Color Presence or absence of odour Taste Surface textures & etc.
  • 25. • Hardness or crushing strength:- The resistance of tablets to capping, abrasion or breakage under conditions of storage, transportation and handling before usage depends on its hardness. It is measured either by Monsanto or Stokes hardness tester, by applying pressure diametrally to the tablet. Monsanto Hardness Tester
  • 26. RESULT IDENTIFICATION OF DRUG: By UV Spectroscopy: Determination of max of Anti hyperglycemic agent: On the basis of preliminary identification test the drug scanned and it was concluded that the drug had max of 232 nm which was equal to max 232nm as reported (std.). SPECTRUM POINT PICK METHOD
  • 27. STABILITY STUDIES  The stability studies were carried out by storing in HDPE containers under the Accelerated stability conditions of 40ºC /70% RH for a period of 1 month.  The tablets were evaluated for the parameters like weight variation, hardness, friability, thickness, and percentage of drug content were evaluated for initial, 1st, 2nd, 3rd and 1month.  The tablets displayed all parameters of optimized formulation F10 within specified limits indicating the stability of the formulation. Parameters 1st week 2nd week 3rd week 4th week Weight variation (mg) 750±5 750±4 750±4 750±4 Thickness (mm) 5.75±0.6 5.75±0.7 5.75±0.7 5.74±0.6 Hardness (N) 180 ± 10 190 ± 10 185±10 180 ± 20 Friability (%) 0.045 0.15 0.15 0.015 Drug Content (%) 97 96 95 94 Stability Studies Of Metformin Prolonged Release Tablets
  • 28. Stability Effect On In-Vitro Dissolution Of Optimized Formulation (F10) at 1,2,3&4 week. Time (Hours) % Drug Release 1st week 2nd week 3rd week 4th week 0 0 0 0 0 1 30 25 28 27 2 42 40 39 44 3 54 54 52 53 6 76 773 74 74 10 98 96 96 95 Stability Effect On In Vitro Drug release profile of Trial-10
  • 29. BIBLIOGRAPHY •United States pharmacopoeia (2008) Bulk density and tapped density, Carr’s index and Hausner’s ratio, USPNF 2008, vol-1, page no: 231- 232. •Indian Pharmacopoeia (2012) Uniformity of weight of single dose preparations, Friability, 2010, vol-1, page no: 140, 192-193. •Lachman L. and Lieberman H.A., Pharmaceutical Dosage Forms, In; Tablets, Vol. 2, Marcel Dekker, Inc., New York ,1989 pp.367-414 •Martin,A.; Physical pharmacy; Fourth edition ; PP 444-445. •www.wikipedia.org/wiki/tablets •www.pharmainfo.net/tablets/types-tablets Remington The Science and Practice of Pharmacy, 21st edition Vol.-1, Page No.1178-1198 •www.Drugbank.com
  • 30. •Brahmankar D.M., Jaiswal S.B., “Biopharmaceutics & Pharmacokinetics”; First Edition; p-335 (1995). •Tripathi KD, Essential of medical pharmacology, 5th ed.New Delhi: Jaypeebrothepublishing house;2003, 254-275. •United States pharmacopoeia (2012) Bulk density and tapped density, Carr’s index and Hausner’s ratio, USPNF 2008, vol-1, page no: 231-232. •Indian Pharmacopoeia (2012) Uniformity of weight of single dose preparations, Friability, 2010, vol-1, page no: 140, 192-193. •British Pharmacopoeia (2012) Angle of repose, vol-5, Appendix- A465.
  • 31. •http://www.researchwikis.com/Generics_Market_Analysis_Marketin g_ Research. •United States pharmacopoeia (2012) Bulk density and tapped density, Carr’s index and Hausner’s ratio, USPNF 2008, vol-1, page no: 231- 232.

Editor's Notes

  1. Subject the blend for tablet formulation (compression)